Novel compounds
The present invention relates to novel compounds useful as inhibitors of NLRP3 inflammasome production wherein such compounds are as defined by compounds of formula (I), and wherein the whole R1, R2 and R3 are defined in the specification, and wherein these compounds can be used as medicaments, for...
Saved in:
| Main Authors | , , , , , , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
30.05.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to novel compounds useful as inhibitors of NLRP3 inflammasome production wherein such compounds are as defined by compounds of formula (I), and wherein the whole R1, R2 and R3 are defined in the specification, and wherein these compounds can be used as medicaments, for example, in the treatment of diseases or disorders associated with NLRP3 inflammasome activity.
本发明涉及用作NLRP3炎症小体产生抑制剂的新型化合物，其中这样的化合物如通过具有式(I)的化合物所定义，并且其中完整体R1、R2和R3在本说明书中所定义，并且其中这些化合物可以用作药剂，例如用于治疗与NLRP3炎症小体活性相关的疾病或障碍。 |
|---|---|
| AbstractList | The present invention relates to novel compounds useful as inhibitors of NLRP3 inflammasome production wherein such compounds are as defined by compounds of formula (I), and wherein the whole R1, R2 and R3 are defined in the specification, and wherein these compounds can be used as medicaments, for example, in the treatment of diseases or disorders associated with NLRP3 inflammasome activity.
本发明涉及用作NLRP3炎症小体产生抑制剂的新型化合物，其中这样的化合物如通过具有式(I)的化合物所定义，并且其中完整体R1、R2和R3在本说明书中所定义，并且其中这些化合物可以用作药剂，例如用于治疗与NLRP3炎症小体活性相关的疾病或障碍。 |
| Author | LABELLIACROS JORGE VAN GOOL MARCELLINUS L. M VAN OPDEN BOSCH NIELS OEHLRICH DANIEL TRESADERN GARY JOHN LANCANFI MICHELE VAN LOMPE DIRK |
| Author_xml | – fullname: VAN LOMPE DIRK – fullname: LANCANFI MICHELE – fullname: VAN OPDEN BOSCH NIELS – fullname: OEHLRICH DANIEL – fullname: VAN GOOL MARCELLINUS L. M – fullname: TRESADERN GARY JOHN – fullname: LABELLIACROS JORGE |
| BookMark | eNrjYmDJy89L5WTg98svS81RSM7PLcgvzUsp5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoZmhpYmJiamjsbEqAEASEggtg |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 新化合物 |
| ExternalDocumentID | CN116194445A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CN116194445A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:56:40 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CN116194445A3 |
| Notes | Application Number: CN202180064526 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230530&DB=EPODOC&CC=CN&NR=116194445A |
| ParticipantIDs | epo_espacenet_CN116194445A |
| PublicationCentury | 2000 |
| PublicationDate | 20230530 |
| PublicationDateYYYYMMDD | 2023-05-30 |
| PublicationDate_xml | – month: 05 year: 2023 text: 20230530 day: 30 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | JANSSEN PHARMACEUTICA N.V |
| RelatedCompanies_xml | – name: JANSSEN PHARMACEUTICA N.V |
| Score | 3.6032014 |
| Snippet | The present invention relates to novel compounds useful as inhibitors of NLRP3 inflammasome production wherein such compounds are as defined by compounds of... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| Title | Novel compounds |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230530&DB=EPODOC&locale=&CC=CN&NR=116194445A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdMMkwElo66ScmGoGlGU2CeSzU20bUE1vVJhinJlskGoL3Dvn5mHqEmXhGmEUwMWbC9MOBzQsvBhyMCc1QyML-XgMvrAsQglgt4bWWxflImUCjf3i3E1kUN2jsGtqdNjQ3UXJxsXQP8Xfyd1ZydbZ391PyCbA0NQd11ExNTR2YGVmAz2hyUG1zDnEC7UgqQqxQ3QQa2AKBpeSVCDExVGcIMnM6wm9eEGTh8oRPeQCY07xWLMPD75Zel5iiA1oCDrkIqFmVQdHMNcfbQBZocD_dGvLMfwhHGYgwswO59qgSDgmFykrlxmoGpBSjMLFMsk5ISLY3MzZMsEg2AYWiRKMkghdscKXyS0gxcoCABz3UbyDCwlBSVpsoCq9CSJDmw3wGXcHMZ |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdMMkwElo66ScmGoGlGU2CeSzU20bUE1vVJhinJlskGoL3Dvn5mHqEmXhGmEUwMWbC9MOBzQsvBhyMCc1QyML-XgMvrAsQglgt4bWWxflImUCjf3i3E1kUN2jsGtqdNjQ3UXJxsXQP8Xfyd1ZydbZ391PyCbA0NQd11ExNTR2YGVmAT2xyUG1zDnEC7UgqQqxQ3QQa2AKBpeSVCDExVGcIMnM6wm9eEGTh8oRPeQCY07xWLMPD75Zel5iiA1oCDrkIqFmVQdHMNcfbQBZocD_dGvLMfwhHGYgwswO59qgSDgmFykrlxmoGpBSjMLFMsk5ISLY3MzZMsEg2AYWiRKMkghdscKXyS8gycHiG-PvE-nn7e0gxcoOABz3sbyDCwlBSVpsoCq9OSJDlwOAAAJ2x2DA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Novel+compounds&rft.inventor=VAN+LOMPE+DIRK&rft.inventor=LANCANFI+MICHELE&rft.inventor=VAN+OPDEN+BOSCH+NIELS&rft.inventor=OEHLRICH+DANIEL&rft.inventor=VAN+GOOL+MARCELLINUS+L.+M&rft.inventor=TRESADERN+GARY+JOHN&rft.inventor=LABELLIACROS+JORGE&rft.date=2023-05-30&rft.externalDBID=A&rft.externalDocID=CN116194445A |